Open access
Open access
Powered by Google Translator Translator

Mon March 30 – 10 Stories of The Day!

30 Mar, 2020 | 02:30h | UTC

 

1 – Venous thromboembolic diseases: diagnosis, management and thrombophilia testing – National Institute for Health and Care Excellence

 

2 – Management of Critically Ill Adults With COVID-19 – JAMA

Editorial: Toward Universal Deployable Guidelines for the Care of Patients With COVID-19

Original Guideline: Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19) – Intensive Care Medicine AND Infographics: The Surviving Sepsis Campaign Rapid Guidelines on the Management of Critically Ill Adults with COVID-19

Related Summary: Surviving Sepsis Campaign: COVID-19 Recommendations – CanadiEm

Related Guideline: COVID-19 rapid guideline: critical care – National Institute for Health and Care Excellence

 

3 – Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma – JAMA

Editorial: Convalescent Plasma to Treat COVID-19: Possibilities and Challenges

Commentaries: A new report raises hope that the blood of recovered patients can help treat severe coronavirus cases – Business Insider AND Plasma transfusion shows promise for COVID-19 treatment, says China study – UPI

See also: Investigational COVID-19 Convalescent Plasma – Emergency INDs – U.S. Food & Drug Administration

 

4 – COVID-19: Controversies on the Use of Face Masks

Related Guidance: WHO Recommendations on when and how to use masks – World Health Organization AND Strategies for Optimizing the Supply of Facemasks – Centers for Disease Control and Prevention

 

5 – N95 Re-Use Instructions – SAGES

Related: Conserving Supply of Personal Protective Equipment—A Call for Ideas – JAMA AND N95 mask can be decontaminated without decreasing filtration efficiency – Stanford Medicine

 

6 – Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers – Hypertension

Commentary: COVID-19 alert: Heart and kidney patients should keep taking their medicines – University of Miami Miller School of Medicine

Related Guidelines: HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19 – American College of Cardiology AND The Renal Association, UK position statement on COVID-19 and ACE Inhibitor/Angiotensin Receptor Blocker use AND Position Statement of the ESC Council on Hypertension on ACE-Inhibitors and Angiotensin Receptor Blockers – European Society of Cardiology 

Related Article: Is There an Association Between COVID-19 Mortality and the Renin-Angiotensin System—a Call for Epidemiologic Investigations – Clinical Infectious Diseases

 

7 – A War on Two Fronts: Cancer Care in the Time of COVID-19 – Annals of Internal Medicine

Related Guidelines: COVID-19 rapid guideline: delivery of systemic anticancer treatments – National Institute for Health and Care Excellence AND Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal – Journal of the National Comprehensive Cancer Network

 

8 – Primary care & Coronavirus (COVID 19): key guidance, information and support – Medium

Related: Coronavirus disease 2019 (covid-19): a guide for UK GPs – The BMJ AND Covid-19: a remote assessment in primary care

 

9 – Potential Effects of Coronaviruses on the Cardiovascular System: A Review – JAMA Cardiology

Editorial: Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality

Related Articles: Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China – JAMA Cardiology AND Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) – JAMA Cardiology

Commentary: A Heart Attack? No, It Was the Coronavirus – The New York Times

 

10 – Coronavirus Disease (COVID-19) Updates / 30 March 2020 Edition

30 March 2020 Edition – COVID-19/SARS-CoV-2 Latest Articles, Guidelines, News & Perspectives (several free resources)

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.